43. Schwelberger HG, Drasche A, Petersen J, Raithel M. Genetic
polymorphisms of histamine degrading enzymes: from small-
scale screening to high-throughput routine testing.
Inflamm Res
2003; 52 (Suppl.): S71-3.
44. Petersen J, Raithel M, Schwelberger HG. Histamine
N
-methyl-
transferase and diamine oxidase gene polymorphisms in
patients with inflammatory and neoplastic intestinal diseases.
Inflamm Res
2002; 51(Suppl.): S91-2.
45. Deindl P, Peri-Jerkan S, Deichmann K et al. No association of his-
tamine-
N
-methyltransferase polymorphism with asthma or
bronchial hyperresponsiveness in two German pediatric popula-
tions.
Pediatr Allergy Immunol
2005; 1 6: 40-2.
46. Sharma S, Mann D, Singh TP, Ghosh B. Lack of association of his-
tamine-
N
-methyltransferase (HNMT) polymorphisms with
asthma in the Indian population.
J Hum Genet
2005; 50: 611-7.
47. Morrow JD, Margolies GR, Rowland J, Roberts LJ. Evidence that
histamine is the causative toxin of scombroid-fish poisoning.
N
Engl J Med
1991; 324: 716-20.
48. Sattler J, Hafner D, Klotter HJ, Lorenz W, Wagner PK. Food-
induced histaminosis as an epidemiological problem: plasma
histamine elevation and haemodynamic alterations after oral
histamine administration and blockade of diamine oxidase
(DAO).
Agents Actions
1988; 23: 361-5.
49. Sattler J, Lorenz W. Intestinal diamine oxidases and enteral-induced
histaminosis: studies on three prognostic variables in an epidemio-
logical model.
J Neural Transm Suppl
1990; 32: 291-314.
50. Sattler J, Lorenz W, Kubo K, Schmal A, Sauer S, Luben L. Foodin-
duced histaminosis under diamine oxidase (DAO) blockade in
pigs: further evidence of the key role of elevated plasma hista-
mine levels as demonstrated by successful prophylaxis with anti-
histamines.
Agents Actions
1989; 27: 212-4.
51. Hershko AY, Dranitzki Z, Ulmanski R, Levi-Schaffer F, Naparstek Y.
Constitutive hyperhistaminaemia: a possible mechanism for
recurrent anaphylaxis.
Scand J Clin Lab Invest
2001; 61: 449-52.
52. Wohrl S, Hemmer W, Focke M, Rappersberger K, Jarisch R. Hista-
mine intolerance-like symptoms in healthy volunteers after oral
provocation with liquid histamine.
Allergy Asthma Proc
2004;
25: 305-11.
53. Thomsen LL, Olesen J. Nitric oxide in primary headaches.
Curr
Opin Neurol
2001; 14: 315-21.
54. Huszti Z. Histamine in CNS-resident non-neuronal cells. En Falus
A, Grosman N, Darvas Z, eds. Histamine: biology and medical
aspects. Budapest, Springer Med Pub., 2004: 272-80.
55. Schmidt WU, Sattler J, Hesterberg R et al. Human intestinal
diamine oxidase (DAO) activity in Crohn’s disease: a new marker
for disease assessment?
Agents Actions
1990; 30: 267-70.
56. Kuefner MA, Schwelberger HG, Weidenhiller M, Hahn EG, Raithel
M. Both catabolic pathways of histamine via histamine-
N
methyl-
transferase and diamine oxidase are diminished in the colonic
mucosa of patients with food allergy.
Inflamm Res
2004; 53
(Suppl.): S31-2.
57. Sarkadi L. Histamine in food. En: Falus A, Grosman N, Darvas Z,
eds. Histamine: biology and medical aspects. Budapest, Springer
Med Publishing, 2004: 176-85.
58. Nordic Council of Ministers. Present status of biogenic amines in
foods in Nordic countries.
Tema Nord
2002: 524 (ISBN: 92-
893-0773-0).
59. Kanny G, Gerbaux V, Olszewski A et al. No correlation between
wine intolerance and histamine content of wine.
J Allergy Clin
Immunol
2001; 107: 375-8.
60. Wohrl S, Hemmer W, Focke M, Rappersberger K, Jarisch R. Hista-
mine intolerance-like symptoms in healthy volunteers after oral
provocation with liquid histamine.
Allergy Asthma Proc
2004;
25: 305-11.
61. Ferran M, Calvet J, Almirall M, Pujol RM, Maymó J. Alopecia
areata as another immune-mediated disease developed in
patients treated with tumour necrosis factor-
α
blocker agents.
Report of five cases and review of the literature.
J Eur Acad Der-
matol Venereol
2010; 24 (25 Junio; DOI 10.1111/j.1468-
3083.2010.03770.x
62. Agesta N, Zabala R, Díaz-Pérez JL. Alopecia areata during inter-
feron alpha-2b/Ribavirin therapy.
Dermatology
2002; 205:
300-1.
63. Radny P, Bauer J, Caroli UM et al. Alopecia areata indued by adju-
vant treatment with alpha-interpheron in malignant melanoma ?.
Dermatology
2004; 209: 249-50.
64. Selleri S, Seltmann H, Gariboldi S et al. Doxorubicin-induced
alopecia is associated with sebaceous gland degeneration.
J Invest Dermatol
2006; 126: 711-20.
65. Sanli H, Kusak F, Arat M, Edmekci P, Ilhan O. Simultaneous onset
of chronic graft versus host disease and alopecia areata following
allogenic haematopoietic cell transplantation.
Acta Derm
Venereol
2004; 84: 86-7.
66. Guida B, De Martino CD, De Martino SD, et al. Histamine plasma
levels and elimination diet in chronic idiopathic urticaria.
Eur J
Clin Nutr
2000; 54: 155-8.
67. Brenninkmeijer EEA, Schram ME, Leeflang MMG, Bos JD, Spuls
Ph.I. Diagnostic criteries for atopic dermatitis: a systematic
review.
Br J Dermatol
2008; 158: 754-65.
68. Ring J, Sedlmeier F, Dorsch W, Hermann K. In vitro IgE eluation
and histamine releasability from peripheral leukocytes of atopics
and normals.
J Dermatol Sci
1991; 2: 413-21.
69. Maintz L, Benfadal S, Allam JP, Hagemann T, Fimmers R, Novak
N. Evidence for a reduced histamine degradation capacity in a
subgroup of patients with atopic eczema.
J Allergy Clin Immunol
2006; 117: 1106-12.
70. Elmore BO, Bollinger JA, Dooley DM. Human kidney diamine oxi-
dase: heterologous expression, purification, and characterization.
J Biol Inorg Chem
2002; 7: 565-79.
71. Ignesti G. Equations of substrate-inhibition kinetics applied to pig
kidney diamine oxidase (DAO, E.C. 1.4.3.6).
J Enzyme Inhib Med
Chem
2003; 18: 463-73.
72. Finch J, Munhutu MN, Whitaker-Worth DL. Atopic dermatitis and
nutrition.
Clin Dermatol
2010; 28: 605-14.
73. Suh K-Y. Food allergy and atopic dermatitis: Separating fact from
fiction.
Semin Cut Med Surg
2010; 29: 72-8.
74. Tedeschi A, Lorini M, Suli C, Cugno M. Detection of serum hista-
mine-releasing factors in a patient with idiopathic anaphylaxis
and multiple drug allergy syndrome.
J Investig Allergol Immunol
2007; 17: 122-5.
75. Mansueto P, Montalto G, Pacor ML et al. Food allergy in gastroen-
terologic diseases: Review of literature.
World J Gastroenterol
2006; 12: 7744-52.
76. Yagami A, Inaba Y, Kuno Y et al. Two cases of pollen-food allergy
syndrome to soy milk diagnosed by skin prick test, specific
serum immunoglobulin E and microarray analysis.
J Dermatol
2009; 36: 50-5.
77. Yagami A, Nakazawa Y, Suzuki K, Matsunaga K. Curry spice allergy
associated with pollen-food allergy syndrome and latex fruit-syn-
drome.
J Dermatol
2009; 36: 45-9.
78. Osawa R, Konno S, Akiyama M et al. Japanese-specific filaggrin
gene mutation in Japanese patients suffering from atopic
eczema and asthma.
J Invest Dermatol
2010; 130: 2834-6.
79. Jarisch R. Histamin-Intoleranz.
Aerztemagazin
2004; 8: 1-4.
79. Kufner MA, Ulrich P, Raithel M, Schwelberger HG. Determination
of histamine degradation capacity in extremely small human
colon samples.
Inflamm Res
2001; 50 (Suppl.): S96-7.
80. Klocker J, Perkmann R, Klein-Weigel P et al. Continuous adminis-
tration of heparin in patients with deep vein thrombosis can
increase plasma levels of diamine oxidase.
Vascul Pharmacol
2004; 40: 293-300.
81. Biebl M, Klocker J, Perkmann R et al. Effects of unfractionated
and low molecular weight heparins on diamine oxidase release.
Inflamm Res
2003; 52 (Suppl.): S63-4.
82. Biebl M, Klocker J, Perkmann R et al. Heparin-induced diamine
oxidase release into the circulation in pigs.
Inflamm Res
2002;
51 (Suppl.): S93-4.
83. Mayer I, Missbichler A, Wantke F, et al. Optimierter Radioextrak-
tionsassay zur quantitativen Bestimmung der Aktivita¨t von
Diaminooxidase (DAO) in humanem Serum und Plasma.
Aller-
gologie
2005; 28: 1-8.
84. Fiedler EM, Pelchrzim R, Focke M, Zuberbier T, Worm M. Bedeu-
tungvon exogen zugefu¨hrtem Histamin bei Patienten mit
atopischer Dermatitis.
Allergo J
2004; 13: S49-50.
85. Hamilton RG. Clinical laboratory assessment of immediate-type
hypersensitivity.
J Allergy Clin Immunol
2010; 125: s284-96.
volumen 24 • nº 1 •
enero-febrero 2011
37
1...,30,31,32,33,34,35,36,37,38,39 41,42,43,44,45,46,47,48,49,50,...92